Dr. Lal PathLabs Ltd (BOM:539524)
₹ 3032.8 -65.45 (-2.11%) Market Cap: 252.57 Bil Enterprise Value: 242.94 Bil PE Ratio: 63.01 PB Ratio: 12.63 GF Score: 99/100

Q3 2020 Dr. Lal PathLabs Ltd Earnings Call Transcript

Feb 03, 2020 / 11:00AM GMT
Release Date Price: ₹1736.2 (-2.14%)
Operator

Ladies and gentlemen, good day. And welcome to Dr. Lal PathLabs Q3 and 9 Months FY '20 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Siddharth Rangnekar from CDR India. Thank you, and over to you, sir.

Siddharth Rangnekar
Citigate Dewe Rogerson Communications Private Limited - IR Manager

Thank you. Good afternoon, everyone, and welcome to Dr. Lal PathLabs Quarter 3 and 9M FY '20 Earnings conference Call. Joining us today are senior members of the management team, including Honorary Brigadier, Dr. Arvind Lal, Chairman and Managing Director; Dr. Om Prakash Manchanda, Whole Time Director and CEO; and Mr. Ved Prakash Goel, CFO. We also have with us, Mr. Bharath, CEO, India Business; and Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

Before we commence the call, I would like to underline that some of the statements made on today's call could be forward-looking in nature and actual results may vary from these forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot